DSM sells 65% stake in caprolactam, acrylonitrile and composite resins businesses to CVC
10:24 AM | March 16, 2015 | Deepti Ramesh
The enterprise value of the transaction is €600 million ($674.8 million) plus an earnout of up to €175 million. Net cash proceeds at closing to DSM will be about €300–350 million.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.